首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury
【24h】

Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury

机译:心肌缺血再灌注损伤的长度非致rNA

获取原文
           

摘要

Following an acute myocardial infarction, reperfusion therapy is currently the most effective way to save the ischemic myocardium; however, restoring blood flow may lead to a myocardial ischemia-reperfusion injury (MIRI). Recent studies have confirmed that long-chain noncoding RNAs (LncRNAs) play important roles in the pathophysiology of MIRIs. These LncRNA-mediated roles include cardiomyocyte apoptosis, autophagy, necrosis, oxidative stress, inflammation, mitochondrial dysfunction, and calcium overload, which are regulated through the expression of target genes. Thus, LncRNAs may be used as clinical diagnostic markers and therapeutic targets to treat or prevent MIRI. This review evaluates the research on LncRNAs involved in MIRIs and provides new ideas for preventing and treating this type of injury.
机译:急性心肌梗死后,再灌注治疗目前是拯救缺血性心肌的最有效方法; 然而,恢复血液流量可能导致心肌缺血再灌注损伤(Miri)。 最近的研究证实,长链非分量RNA(LNCRNA)在MIRI的病理生理学中起重要作用。 这些LNCRNA介导的角色包括心肌细胞凋亡,自噬,坏死,氧化应激,炎症,线粒体功能障碍和钙过载,其通过靶基因的表达来调节。 因此,LNCRNA可以用作临床诊断标记和治疗或预防MIRI的治疗靶标。 该审查评估了涉及MIRIS涉及的LNCRNA的研究,并为预防和治疗这种伤害提供新的思路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号